Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/CGEM/Revenue

CULLINAN THERAPEUTICS, INC. (CGEM) Revenue 2020–2022

CULLINAN THERAPEUTICS, INC. (CGEM) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

$0FY2022 · since FY2020: $0 → $0
202122
Fiscal yearValueYoY
FY2022$0-100.0%
FY2021$18.9M—
FY2020$0—

Source: SEC XBRL filings · For reference only · Not investment advice

More CGEM financial trends

CGEM Net incomeCGEM Net marginCGEM Gross profitCGEM Gross marginCGEM Operating incomeCGEM Operating marginCGEM Operating cash flowCGEM Free cash flowCGEM Capital expendituresCGEM Return on equityCGEM Stock buybacksCGEM Dividends paidCGEM Total assetsCGEM Total liabilitiesCGEM Shareholders’ equityCGEM overview →